San Francisco, California, June 08, 2017: The report titled, “Sterility Testing Market– Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017-2025” by TMR Research discusses the major trends, developments, and growth drivers of the market, alongside market projections. The report also covers key challenges, market attractiveness, value chain analysis, and an analysis of technological advancements.
Final drug offerings, raw materials, and cell banks are some key application areas using sterility testing. The testing of various substances that have to be made sterile according to the regulations of the European Pharmacopoeia as well as the United States Pharmacopoeia also needs sterility testing. Sterility testing can be conducted in a clean room atmosphere or an isolator that uses direct inoculation method or membrane filtration.
Increasing number of research and development projects in life sciences, expansion of the fields such as pharmaceutical and bio technology, and innovation of novel drugs are some of the top most catalysts of the global sterility testing market. Due to the remarkable growth in the bio technology and pharmaceutical sectors, the biological & pharmaceutical manufacturing segment achieved a gigantic share in the global sterility testing market in 2016.
During the same year, based on test type, the membrane filtration segment accounted for the largest share of the global market for sterility testing. Of recent, the demand for kit based testing as well as repeat purchase requirement has been augmenting. Consequently, the kits and reagents segment is expected to contribute a significant revenue to the overall market for sterility testing.
The countries in Asia Pacific possess maximum potential for growth, and thus will witness a speedy growth of the global sterility testing market. Augmenting at a high CAGR, Asia Pacific is expected to represent the largest chunk of the global market for sterility testing.
The rising outsourcing in the pharmaceutical sector to the emerging nations such as India and China is one of the key factors responsible for the growth of this region. Escalating outlay on research in life sciences is another growth driver supporting the success of the sterility testing market in the region. North America is slated to achieve a substantial share in the global sterility testing market as well. The Rest of the World (RoW) might also contribute significantly to the total market.
Based on competition, the global sterility testing market is consolidated. The extreme degree of competition between the key vendors is likely to make it difficult for new entrants to gain a strong foothold in the global sterility testing market. One of the key stumbling blocks for market players is tiresome and lengthy approval procedures. Stringent regulatory policies can also hinder product approvals.
Merck KgaA, WuXi AppTec, bioMerieux SA, Thermo Fisher Scientific, Inc., Sartorius AG, Charles River Laboratories International, Inc., SGS SA are some major firms operating global sterility testing market.